CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-03-29 to 2026-06-27

Swipe to see the full flow
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash flow reconciliation, Mar 29, 2026 through Jun 27, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Depreciation and amortization → operating reconciliation: $67,290,000.00Deferred income taxes → operating reconciliation: $41,494,000.00Remaining operating cash flows, net (calculated) → operating reconciliation: $24,921,000.00Other, net → operating reconciliation: $22,080,000.00Stock-based compensation → operating reconciliation: $19,781,000.00Accrued compensation → operating reconciliation: $18,900,000.00Inventories → operating reconciliation: $17,743,000.00Long-lived asset impairments → operating reconciliation: $10,416,000.00Write down of inventories → operating reconciliation: $1,676,000.00Provision for credit losses → operating reconciliation: $1,077,000.00Accounts payable → operating reconciliation: $821,000.00Deferred revenue → operating reconciliation: $396,000.00operating reconciliation → Net cash from operating activities: $179,725,000.00operating reconciliation → Net income (loss): $760,000.00operating reconciliation → Trade receivables and contract assets, net: $21,816,000.00operating reconciliation → Other assets and liabilities, net: $11,812,000.00operating reconciliation → (Gains) losses and impairments on venture capital and strategic equity investments, net: $8,074,000.00operating reconciliation → Customer contract deposits: $4,408,000.00Proceeds from sale of businesses and assets, net → investing reconciliation: $116,467,000.00Proceeds from sale of investments → investing reconciliation: $8,137,000.00Other, net → investing reconciliation: $159,000.00investing reconciliation → Net cash from investing activities: $28,097,000.00investing reconciliation → Acquisition of businesses and assets, net of cash acquired: $62,248,000.00investing reconciliation → Capital expenditures: $31,105,000.00investing reconciliation → Purchases of investments and contributions to venture capital investments: $3,313,000.00Net cash used in financing activities → financing reconciliation: $164,661,000.00Proceeds from long-term debt and revolving credit facility → financing reconciliation: $352,796,000.00Proceeds from exercises of stock options → financing reconciliation: $397,000.00financing reconciliation → Payments on long-term debt, revolving credit facility, and finance lease obligations: $390,251,000.00financing reconciliation → Purchase of treasury stock: $115,596,000.00financing reconciliation → Payments of contingent consideration: $11,400,000.00financing reconciliation → Other, net: $607,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $198,201,000.00Net cash from operating activities → Cash sources and uses: $179,725,000.00Net cash from investing activities → Cash sources and uses: $28,097,000.00Cash sources and uses → Exchange-rate effect: $781,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $240,581,000.00Cash sources and uses → Net cash used in financing activities: $164,661,000.00Net income (loss): -$760,000.00Net income (loss)−$760.00 KDepreciation and amortization: $67,290,000.00Depreciation & amortization+$67.29 MLong-lived asset impairments: $10,416,000.00Long-lived asset impairment+$10.42 MStock-based compensation: $19,781,000.00Stock-based compensation+$19.78 MDeferred income taxes: $41,494,000.00Deferred taxes & credits+$41.49 MWrite down of inventories: $1,676,000.00Inventory write-downs+$1.68 M(Gains) losses and impairments on venture capital and strategic equity investments, net: -$8,074,000.00Venture & strategic gain & loss−$8.07 MProvision for credit losses: $1,077,000.00Credit loss provision+$1.08 MOther, net: $22,080,000.00Other non-cash items+$22.08 MTrade receivables and contract assets, net: -$21,816,000.00Accounts receivable−$21.82 MInventories: $17,743,000.00Inventories+$17.74 MAccounts payable: $821,000.00Accounts payable+$821.00 KAccrued compensation: $18,900,000.00Accrued compensation+$18.90 MDeferred revenue: $396,000.00Deferred revenue+$396.00 KCustomer contract deposits: -$4,408,000.00Customer contract deposits−$4.41 MOther assets and liabilities, net: -$11,812,000.00Other working capital, net−$11.81 MRemaining operating cash flows, net (calculated): $24,921,000.00Remaining operating (calculated)+$24.92 MNet cash from operating activities: $179,725,000.00Operating cash+$179.73 Moperating reconciliation: $226,595,000.00Proceeds from long-term debt and revolving credit facility: $352,796,000.00Long-term debt issued+$352.80 MPayments on long-term debt, revolving credit facility, and finance lease obligations: -$390,251,000.00Debt & capital securities repaid−$390.25 MProceeds from exercises of stock options: $397,000.00Stock option exercises+$397.00 KPurchase of treasury stock: -$115,596,000.00Common stock repurchases−$115.60 MPayments of contingent consideration: -$11,400,000.00Contingent consideration paid−$11.40 MPurchase of remaining equity interests of other redeemable noncontrolling interest: $0.00Other, net: -$607,000.00Other financing, net−$607.00 KNet cash used in financing activities: -$164,661,000.00. Cash required to fund net payments.Financing cash−$164.66 Mfinancing reconciliation: $517,854,000.00Acquisition of businesses and assets, net of cash acquired: -$62,248,000.00Acquisitions, net of cash−$62.25 MCapital expenditures: -$31,105,000.00Capital expenditures−$31.11 MPurchases of investments and contributions to venture capital investments: -$3,313,000.00Investment purchases−$3.31 MProceeds from sale of investments: $8,137,000.00Marketable securities proceeds+$8.14 MProceeds from sale of businesses and assets, net: $116,467,000.00Business & asset sales+$116.47 MOther, net: $159,000.00Other investing, net+$159.00 KNet cash from investing activities: $28,097,000.00Investing cash+$28.10 Minvesting reconciliation: $124,763,000.00Cash sources and uses: $406,023,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $198,201,000.00Beginning cash$198.20 MEnding cash: Cash, cash equivalents, and restricted cash: $240,581,000.00Ending cash$240.58 MExchange-rate effect: -$781,000.00FX effect−$781.00 KCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsNet loss −$760.00K + net operating adjustments $180.49M = operating cash +$179.73MFree cash flow$148.62 MOperating cash − cash spent on productive assetsCash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$42.38 MEnding cash − beginning cash
Chart details

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash flow reconciliation, Mar 29, 2026 through Jun 27, 2026

Cash flows for Mar 29, 2026 through Jun 27, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 28, 2026. Ending cash: Jun 27, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 28, 2026
198,201,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
179,725,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines ((Gain) loss on divestitures, net), so (Gain) loss on divestitures, net and Gain on sale of assets cannot be separated for this quarter. It may combine inflows and outflows.
Net income (loss)
negative 760,000 US dollars
Depreciation and amortization
67,290,000 US dollars
Long-lived asset impairments
10,416,000 US dollars
Stock-based compensation
19,781,000 US dollars
Deferred income taxes
41,494,000 US dollars
Write down of inventories
1,676,000 US dollars
(Gains) losses and impairments on venture capital and strategic equity investments, net
negative 8,074,000 US dollars
Provision for credit losses
1,077,000 US dollars
Other, net
22,080,000 US dollars
Trade receivables and contract assets, net
negative 21,816,000 US dollars
Inventories
17,743,000 US dollars
Accounts payable
821,000 US dollars
Accrued compensation
18,900,000 US dollars
Deferred revenue
396,000 US dollars
Customer contract deposits
negative 4,408,000 US dollars
Other assets and liabilities, net
negative 11,812,000 US dollars
Remaining operating cash flows, net (calculated)
24,921,000 US dollars
Investing activities
28,097,000 US dollars. Net cash provided.
Acquisition of businesses and assets, net of cash acquired
negative 62,248,000 US dollars
Capital expenditures
negative 31,105,000 US dollars
Purchases of investments and contributions to venture capital investments
negative 3,313,000 US dollars
Proceeds from sale of investments
8,137,000 US dollars
Proceeds from sale of businesses and assets, net
116,467,000 US dollars
Other, net
159,000 US dollars
Financing activities
negative 164,661,000 US dollars. Net cash used.
Proceeds from long-term debt and revolving credit facility
352,796,000 US dollars
Payments on long-term debt, revolving credit facility, and finance lease obligations
negative 390,251,000 US dollars
Proceeds from exercises of stock options
397,000 US dollars
Purchase of treasury stock
negative 115,596,000 US dollars
Payments of contingent consideration
negative 11,400,000 US dollars
Purchase of remaining equity interests of other redeemable noncontrolling interest
0 US dollars
Other, net
negative 607,000 US dollars
Operating adjustment reconciliation
226,595,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
517,854,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
124,763,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 781,000 US dollars
Ending cash on Jun 27, 2026
240,581,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
406,023,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
42,380,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
179,725,000 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
31,105,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
148,620,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$760.00K + net operating adjustments $180.49M = operating cash +$179.73M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 179,725,000 US dollars minus 31,105,000 US dollars equals 148,620,000 US dollars.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!